Kids Disease Child Disease Encyclopedia
Illustration representing Viral Encephalitis
Emergency Central Nervous System Inflammatory Infections

Viral Encephalitis

Acute Inflammatory Brain Parenchyma Infection

Primary risk age: All pediatric ages (Infants and young children are at higher risk for severe outcomes)

Urgency
Emergency
Typical age
All pediatric ages (Infants and young children are at higher risk for severe outcomes)
Body system
Neurological System

Typical course: Acute hospital treatment spans 10 to 21 days; neurological rehabilitation and recovery can take months to years.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Acute Inflammatory Brain Parenchyma Infection

Pathophysiology (Development Path)

Viruses enter the central nervous system via hematogenous spread or retrograde transport along peripheral nerves (e.g., HSV along the trigeminal nerve). Viral replication inside glial cells and neurons triggers an inflammatory response. This leads to cerebral edema, petechial hemorrhages, and widespread tissue necrosis.

Primary Causes & Etiology

Herpes Simplex Virus Type 1 (HSV-1) or Type 2 (in neonates), Enteroviruses, Arboviruses (such as West Nile or Japanese Encephalitis), and Influenza.

2. Symptom Continuum

  1. Early Onset Signs

    Flu-like illness with mild fever, headache, myalgia, and fatigue lasting 1 to 4 days.

  2. Progressive Phase

    High fever, altered mental status (confusion, lethargy, extreme irritability), behavioral changes, and localized neurological deficits.

  3. Severe Indicators

    Focal or generalized seizures, hemiparesis, cranial nerve palsies, severe cerebral edema leading to herniation, and coma.

3. Clinical Verification

Brain MRI showing localized edema (e.g., temporal lobe involvement classic for HSV). Lumbar puncture showing lymphocytic pleocytosis, normal glucose, and elevated PCR markers for specific viral DNA.

4. Care & Elements Plan

Primary Care Treatment Plan

Initiate immediate intravenous antiviral therapy (Acyclovir) empirically if HSV is suspected. Provide supportive care to manage intracranial pressure, maintain fluid balance, and control seizures.

Home Support Elements

Home care is strictly not applicable. Immediate emergency hospitalization and critical care monitoring are required.

Generic Active Ingredients (No Brands)

  • Acyclovir (intravenous antiviral active ingredient targeting Herpes simplex and Varicella viruses)
  • Fosphenytoin or Levetiracetam (active anticonvulsants used to manage seizures).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Seek immediate emergency care if a child develops a high fever, sudden confusion, extreme lethargy, inability to wake up, or seizure activity.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Avoid mosquito and tick bites by using insect repellent and protective clothing. Practice strict hand hygiene to limit enterovirus spread.

Immunization Context

Prevented in part by MMR, Varicella, and Influenza vaccines. Specific arbovirus vaccines are recommended in endemic regions (e.g., Japanese Encephalitis vaccine).

7. Timelines & Outlook

Active Timeline

Acute hospital treatment spans 10 to 21 days; neurological rehabilitation and recovery can take months to years.

Expected Prognosis

Variable. Enteroviral encephalitis carries a good prognosis. Untreated HSV encephalitis is highly fatal (up to 70%), and survivors often have significant neurological deficits.

Potential Untreated Complications

Persistent epilepsy, cognitive impairment, motor deficits, speech disorders, and hypothalamic-pituitary dysfunction.